22nd week of 2012 patent applcation highlights part 45 |
Patent application number | Title | Published |
20120136122 | PROCESS FOR PRODUCTION OF MODIFIED POLYSILOXANE COMPOUND - A modified polysiloxane compound represented by formula (I): X(Y)n (I), where X represents a polymer block having a repeating unit represented by formula (II), Y represents a polymer block having a repeating unit represented by formula (III), and n represents 1 or 2, and having an X to Y weight ratio of 1/99≦X/Y≦90/10 and a number-average molecular weight of 1,000 to 100,000 is subjected to treat for elimination of a protecting group for a hydroxyl group by adding a non-aqueous solution containing hydrogen chloride in the presence of a non-aqueous solvent so that hydrogen chloride is 0.9 to 1.3 equivalents with respect to 1 equivalent of the repeating unit represented by formula (II). | 2012-05-31 |
20120136123 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same - The present disclosure provides copolymers of 2-substituted-2-oxazolines possessing two or three reactive functional groups which are also chemically orthogonal. The copolymers described may be random copolymers, block copolymers or a mixture of random and block copolymer configurations. Furthermore, the present disclosure provides novel methods for synthesizing the above polymers and for conjugating to molecules such as targeting, diagnostic and therapeutic agents. | 2012-05-31 |
20120136124 | PROCESS TO PREPARE DI- AND MULTIBLOCK COPOLYMERS - The present invention discloses a process for preparing di-, tri, or multi-block polyester/polycarbonate (co)polymers by ring-opening polymerisation in the presence of a non-toxic catalyst system in combination with either a linear monohydroxy HO—PC—OR, or a linear telechelic dihydroxy HO—PC—OH, or a star polyhydroxy R—(PC—OH)n end-capped polyester/polycarbonate. | 2012-05-31 |
20120136125 | SELF-REPAIRING POLYMER - A polymer includes a reaction product of an epoxy resin, a first crosslinking agent, and a second crosslinking agent. The first crosslinking agent is reactive with the epoxy resin and has a first molecular weight. The second crosslinking agent is reactive with the epoxy resin and has a second molecular weight of at least 2.5 times greater than the first molecular weight. The polymer has a first phase having a first glass transition temperature at which the polymer is transformable between a first shape and a second shape. The second crosslinking agent is crystallizable within the polymer and thereby has a melting temperature that is detectable within the polymer. | 2012-05-31 |
20120136126 | DEFORMABLE SHAPE-MEMORY POLYMER - A polymer includes a reaction product of an epoxy resin, a first crosslinking agent, and a second crosslinking agent. The first crosslinking agent is reactive with the epoxy resin and has a first molecular weight. The second crosslinking agent is reactive with the epoxy resin and has a second molecular weight of at least ten times greater than the first molecular weight. The polymer has a first phase having a first glass transition temperature and a second phase having a second glass transition temperature that is lower than the first glass transition temperature. The polymer is transformable between a first shape and a second shape at the first glass transition temperature. | 2012-05-31 |
20120136127 | Polymerization Reaction System - A process for the polymerization of olefins is disclosed. The process may include: feeding a catalyst, a liquid diluent, and an olefin to a polymerization vessel having, from a polymerization vessel bottom to a polymerization vessel top, a vapor introduction zone, a three-phase reaction zone and a vapor disengagement zone; contacting the catalyst and olefin under conditions of temperature and pressure in the presence of the liquid diluent as a continuous phase in the three-phase reaction zone to form a solid phase polyolefin; withdrawing a gas phase composition from an outlet in fluid communication with the vapor disengagement zone; circulating the gas phase composition through a gas circulation loop to an inlet in fluid communication with the vapor distribution zone at a rate sufficient to agitate the solid and liquid phases within the three-phase reaction zone; and withdrawing a reaction mixture comprising polyolefin and diluents from the three-phase reaction zone. | 2012-05-31 |
20120136128 | ANIONIC POLYMERIZATION INITIATORS AND PROCESSES - A group of compounds defined by the general formula (I) can be used to anionically initiate polymerization of unsaturated monomers. In the formula, M is an alkali metal atom, R | 2012-05-31 |
20120136129 | VULCANIZABLE COMPOSITION HAVING ACOUSTIC ATTENTUATING PROPERTIES - The invention relates to a composition that can be thermally cured, containing relative to the total composition, a) 5 to 90% by weight of a diene-based polymer or copolymer containing an olefinic double bond and/or an aromatically substituted olefin, wherein the polymer or copolymer is liquid, or paste-like, at 22° C. and has a glass transition temperature between −30° C. and +15° C., measured according to a DSC method; b) a vulcanization system selected from the group consisting of: b1) sulfur, and one or more accelerator(s), b2) peroxidic or disulfidic vulcanization systems, b3) quinones, quinone dioximes, or dinitrosobenzene. | 2012-05-31 |
20120136130 | ISOBUTYLENE-BASED POLYMER AND METHOD FOR PRODUCING SAME - An isobutylene-based polymer comprising a structural unit represented by the following formula (1): | 2012-05-31 |
20120136131 | POLYMERIZATION INITIATOR FOR LIVING RADICAL POLYMERIZATION - Provided is a method of living radical polymerization which does not necessitate complicated and intricate synthesis of a dormant species and which is highly efficient. A halogenated derivative compound is used as a dormant species for initiating living radical polymerization. The derivative compound is obtained by halogenating an alcohol compound having a non-conjugated structure or an amine compound having a non-conjugated structure with a halogenating agent capable of halogenating an alcohol or amine. A radical produced by elimination of halogen from the halogenated derivative compound is allowed to react with the unsaturated bond of the monomer. Thus, the monomer, which has a radical-reactive unsaturated bond, is polymerized by living radical polymerization. Preferably, the halogenating agent is a compound (NIS or the like) which also has a function as a catalyst. | 2012-05-31 |
20120136132 | PROCESS FOR CONTINUOUS PREPARATION OF HIGH MOLECULAR WEIGHT POLYESTERS BY ESTERIFICATION OF DICARBOXYLIC ACIDS AND/OR TRANSESTERIFICATION OF DICARBOXYLIC ACIDS WITH DIOLS AND/OR MIXTURES THEREOF AND AN APPARATUS THEREFOR - The present invention relates to a method for the continuous production of high-molecular polyesters by esterification of dicarboxylic acids and/or transesterification of dicarboxylic acid esters with diols and/or mixtures thereof in the presence of catalysts with formation of a prepolymer in a tower reactor and polycondensation thereof to form a high-molecular polyester in a polycondensation reactor, a prepolymer with >40 to 70 repeat units (DP) being produced in the tower reactor and this prepolymer being polycondensed in only one further reactor to form a polyester with >150 to 205 DP. | 2012-05-31 |
20120136133 | POLYCONDENSATION CATALYST FOR PRODUCING POLYESTER AND METHOD FOR PRODUCING THE SAME AND METHOD FOR PRODUCING POLYESTER - The invention provides a method for producing a catalyst for producing polyester by an esterification reaction or a transesterification reaction between a dicarboxylic acid or an ester-forming derivative thereof and a glycol, the method comprising hydrolyzing an organic titanium compound in an organic solvent in which particles of a solid base are dispersed thereby to form a coat layer of titanic acid on the surface of the particles of a solid base. | 2012-05-31 |
20120136134 | PROCESS FOR PREPARING A POLYESTER - Disclosed is a process for preparing a polyester or copolymer containing ester functionalities. The process can comprise:
| 2012-05-31 |
20120136135 | THERMOSTABLE BIOPOLYESTER - A biopolyester which is poly(3-hydroxyalkanoate) or poly(3-hydroxyalkanoate) copolymer and has a reduced calcium content. It has improved thermal stability due to the reduced calcium content. | 2012-05-31 |
20120136136 | PROCESS TO INDUCE POLYMERIZATION OF AN ORGANIC ELECTRONICALLY CONDUCTIVE POLYMER - A process to induce polymerization of an organic electronically conductive polymer in the presence of a partially delithiated alkali metal phosphate which acts as the polymerization initiator. | 2012-05-31 |
20120136137 | Method and composition for crystallizing G protein-coupled receptors - Certain embodiments provide a method for crystallizing a GPCR. The method may employ a fusion protein comprising: a) a first portion of a G-protein coupled receptor (GPCR), where the first portion comprises the TM1, TM2, TM3, TM4 and TM5 regions of the GPCR; b) a stable, folded protein insertion; and c) a second portion of the GPCR, where the second portion comprises the TM6 and TM7 regions of the GPCR. | 2012-05-31 |
20120136138 | ICE-CRYSTAL GROWTH INHIBITING SUBSTANCE - An objective to be achieved by the present invention is to provide an ice-crystal growth inhibiting substance which has an excellent ice-crystal growth inhibiting activity suitable for practical use and which can be produced easily, efficiently and economically in safe steps usable in food production. Another objective of the present invention is to provide a method for producing the ice-crystal growth inhibiting substance, a polypeptide which is an active part of the ice-crystal growth inhibiting substance, as well as an ice-crystal growth inhibiting substance composition, a food, a biological sample protectant and a cosmetic each containing the ice-crystal growth inhibiting substance or the polypeptide. The ice-crystal growth inhibiting substance according to the present invention is characterized in that the ice-crystal growth inhibiting substance is derived from a plant, and has a molecular weight of 400 kDa or more as measured by gel filtration chromatography. | 2012-05-31 |
20120136139 | COUNTER-PRESSURE FILTRATION OF PROTEINS - A method is disclosed for filtering a protein in a liquid mixture in a manner that does not substantially damage or otherwise limit the recovery of the protein in the filtration filtrate. The method generally includes passing a liquid mixture containing a protein (e.g., an aqueous vWF mixture) through a filter while applying a counter pressure to the liquid mixture filtrate to accurately reduce and control the pressure differential across the filter. The disclosed method has the advantage that relatively high filtration flow rates can be achieved at relatively low pressure differentials, in contrast to high pressure differentials, which actually reduce the filtration flow rate of protein liquid mixtures. Further, the method can recover substantially all of the protein that is initially present in the liquid mixture. | 2012-05-31 |
20120136140 | ANTI-CADHERIN ANTIBODY - It is an object of the present invention to provide an anti-cadherin antibody having high antibody-dependent cellular cytotoxicity. The present invention provides an anti-cadherin antibody, which recognizes any one of an upstream region of EC1, a cadherin domain 4 (EC4) and a cadherin domain 5 (EC5), wherein an antibody-dependent cellular cytotoxicity at an antibody concentration of 1 μg/mL is 30% or more. | 2012-05-31 |
20120136141 | Integrin Heterodimer And A Subunit Thereof - A recombinant or isolated integrin heterodimer comprising a novel subunit α10 in association with a subunit β is described. The integrin or the subunit α10 can be used as a marker or target of various types of cells, e.g. of chondrocytes, osteoblasts, and fibroblasts. The integrin or the subunit α10 can be used as a marker or target in different physiological or therapeutic methods. They can also be used as active ingredients in pharmaceutical compositions and vaccines. | 2012-05-31 |
20120136142 | Vaccine Compositions For Marburg Virus - Methods and immunogenic compositions for generating an immune response against Marburg virus are provided. The immunogenic composition includes antigens obtained from a Marburg viral strain in combination with an oleanolic acid triterpene adjuvant. | 2012-05-31 |
20120136143 | Methods and Kits for Sense RNA Synthesis - Methods and kits are provided for performing multiple rounds of sense RNA synthesis. The sense RNA molecules can be used in various research and diagnostic applications, such as gene expression studies involving nucleic acid microarrays. | 2012-05-31 |
20120136144 | SIRNA TARGETING CATENIN, BETA-1 (CTNNB1) - Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for CTNNB1. | 2012-05-31 |
20120136145 | Compositions and Methods for Inhibiting Expression of Eg5 Gene - The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of the Eg5 gene (Eg5 gene), comprising an antisense strand having a nucleotide sequence which is less that 30 nucleotides in length, generally 19-25 nucleotides in length, and which is substantially complementary to at least a part of the Eg5 gene. The invention also relates to a pharmaceutical composition comprising the dsRNA together with a pharmaceutically acceptable carrier; methods for treating diseases caused by Eg5 expression and the expression of the Eg5 gene using the pharmaceutical composition; and methods for inhibiting the expression of the Eg5 gene in a cell. | 2012-05-31 |
20120136146 | PROCESS FOR THE PRODUCTION OF MICROFIBRILLATED CELLULOSE AND PRODUCED MICROFIBRILLATED CELLULOSE - A process for producing microfibrillated cellulose comprises providing a slurry comprising cellulosic fibers, treating the slurry with an enzyme, mechanically treating the slurry so that the fibers are disintegrated wherein the mechanical treatment and the treatment with the enzyme is performed simultaneously in a single treatment step. In this way it is possible to produce microfibrillated cellulose (MFC) in an improved and energy efficient way. A microfibrillated cellulose is produced according to the process. | 2012-05-31 |
20120136147 | Method of hydrolyzing an enzymatic substrate - The invention is directed to droplet actuator devices and assay methods. The method may include immobilization of the enzymatic substrate including forming an inclusion complex with the substrate within an aqueous environment in contact with an oil. | 2012-05-31 |
20120136148 | Photochromic Compounds Having At Least Two Photochromic Moieties - The present invention relates to photochromic compounds that include at least two photochromic moieties that are linked together by a multivalent linking group. The multivalent linking group can be selected so as to be flexible and/or substantially prevent electronic interaction between any two photochromic moieties through the multivalent linking group. The present invention also relates to photochromic compositions and articles that include at least a photochromic amount of one or more photochromic compounds of the present invention. | 2012-05-31 |
20120136149 | METHOD FOR PREPARING 5-CHLORO-N-(METHYL)THIOPHEN-2-CARBOXAMIDE DERIVATIVE AND INTERMEDIATE USED THEREIN - Disclosed are: a method for preparing a 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin- | 2012-05-31 |
20120136150 | 4-(3-Butynyl)Aminopyrimidine Derivatives as Pest Control Agents for Agricultural and Horticultural Use - Novel 4-(3-butynyl)aminopyrimidine derivatives represented by general formula [I] are useful as pest control agents. In general formula [I], R | 2012-05-31 |
20120136151 | NOVEL METHOD FOR PREPARING ROSUVASTATIN, INTERMEDIATE COMPOUNDS USEFUL FOR PREPARING SAME, AND METHOD FOR PREPARING SAME - The present invention relates to novel intermediate compounds used in preparing Rosuvastatin or the pharmaceutically acceptable salts thereof, to a method for preparing same, and to a method for preparing Rosuvastatin or the pharmaceutically acceptable salts thereof from the intermediates. The preparation method of the present invention has the effect of providing Rosuvastatin hemi-calcium salts with an excellent yield rate. | 2012-05-31 |
20120136152 | EFFICIENT SYNTHETIC METHOD OF 18F-MEFWAY PRECURSOR - The present invention relates a novel method for preparing an | 2012-05-31 |
20120136153 | CAMPTOTHECIN ANALOGS AND METHODS OF PREPARATION THEREOF - A compound having the formula | 2012-05-31 |
20120136154 | PROCESSES FOR THE PREPARATION OF SUBSTITUTED TETRAHYDRO BETA-CARBOLINES - Provided herein are improved processes for the synthesis of substituted tetrahydro beta-carboline derivatives. In particular, provided herein are improved processes useful for the preparation of (S)-4-chlorophenyl 6-chloro-1-(4-methoxyphenyl)-3,4-dihydro-1H-pyrido[3,4- | 2012-05-31 |
20120136155 | AROMATIC SULFONIUM SALT COMPOUND - Disclosed are a photo-acid generator having high developing properties, a cationic polymerization initiator having high curing properties, and a resist composition and a cationically polymerizable composition containing the photo-acid generator and the cationic polymerization initiator, respectively. Described are a noble aromatic sulfonium salt compound of general formula (I) and a photo-acid generator, a cationic polymerization initiator, a resist composition, and a cationically polymerizable composition containing the compound. | 2012-05-31 |
20120136156 | PROCESS FOR PREPARING PYRIDYL-SUBSTITUTED PYRAZOLES - The present invention relates to a process for preparing 1-pyridyl-substituted pyrazoles, comprising the reaction of acetyleneketones with pyridylhydrazine derivatives to give 1-pyridyl-substituted dihydro-1H-pyrazoles, the further reaction thereof with elimination of water to give 1-pyridyl-substituted trihalomethylpyrazoles, and the further processing thereof. | 2012-05-31 |
20120136157 | ARYL UREAS AS KINASE INHIBITORS - This invention relates to new aryl ureas and methods for their synthesis. The inventive compounds are useful in the treatment of (i) raf mediated diseases, for example, cancer, (ii) p38 mediated diseases such as inflammation and osteoporosis, and (iii) VEGF mediated diseases such as angiogenesis disorders. | 2012-05-31 |
20120136158 | Pyridinyl Compounds Useful As Intermediates - Disclosed are compounds of the formula (I), useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of CCR1 including autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. | 2012-05-31 |
20120136159 | THE METHOD OF SYNTHESIZING ERGOTHIONEINE AND ANALOGS - The present disclosure relates to a method for synthesizing ergothioneine or one of the derivatives thereof of following formula (I): | 2012-05-31 |
20120136160 | PHARMACEUTICAL COMPOSITION - To provide a pharmaceutical composition containing a 2-nitroimidazole derivative, which has high solubility in an aqueous carrier and high stability. | 2012-05-31 |
20120136161 | Method of Synthesizing Organic Molecules - A method of synthesizing organic molecules is provided, wherein the method comprises providing an electrophilic educt, providing an ionic liquid comprising a carbanion, and synthesizing the organic molecules by mixing the electrophilic educt and the ionic liquid. | 2012-05-31 |
20120136162 | PROCESS FOR THE PREPARATION OF PYRAZOLE CARBOXYLIC ACID AMIDES - The invention relates to a process for the preparation of 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (9-dichloromethylene-1,2,3,4-tetrahydro-1,4-methano-naphthalen-5-yl)-amide. | 2012-05-31 |
20120136163 | Method for the Preparation of 1-Acetyl-6-Amino-3,3-Dimethyl-2,3-Dihydroindole - The present invention relates to processes for preparing indoline derivatives, particularly 1-acetyl-6-amino-3,3-dimethyl-2,3-dihydroindole. | 2012-05-31 |
20120136164 | NANOSTRUCTURED METALS - The invention relates to a nanoparticulate material comprising long ultrathin metal nanowires, and to processes for making it. The nanoparticulate material may be used as a catalyst and, in the presence of a chiral modifier, can catalyse enantioselective reactions. | 2012-05-31 |
20120136165 | PROCESS - The present invention provides a continuous process for the epoxidation of an olefinic compound with an oxidant, which process comprises reaction of an olefinic compound with an oxidant in the presence of a catalyst in an apparatus that comprises
| 2012-05-31 |
20120136166 | PROCESS FOR THE PRODUCTION OF AN OLEFIN OXIDE - The invention provides a process for the epoxidation of an olefin, which process comprises reacting a feed comprising an olefin and oxygen in the presence of a catalyst comprising a carrier and silver deposited on the carrier, which carrier comprises at least 85 weight percent α-alumina and has a surface area of at least 1.3 m | 2012-05-31 |
20120136167 | Processes For The Preparation Of Optically Active Intermediates - This invention relates to processes for the production of optically active 2-(disubstituted aryl)cyclopropylamine compounds and optically active 2-(disubstituted aryl) cyclopropane carboxamide compounds which are useful intermediates for the preparation of pharmaceutical agents, and in particular the compound [1S-(1α,2α,3β(1S*,2R*),5β]-3-[7-[2-(3,4-difluorophenyl)-cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)-cyclopentane-1,2-diol. | 2012-05-31 |
20120136168 | ESTERS OF SECONDARY HYDROXY FATTY ACID OLIGOMERS AND PREPARATION THEREOF - Prepare an ester of a secondary hydroxy fatty acid oligomer by first partially homopolymerizing a hydroxylated fatty acid compound, reacting the partially homopolymerized hydroxylated fatty acid compound with an alcohol to form an intermediate product, and capping the intermediate product with an acid, acid anhydride or ester. The ester of a secondary hydroxy fatty acid oligomer may be represented as follows: (3) where R is an alkyl group that contains from six to twelve carbon atoms, R | 2012-05-31 |
20120136169 | POLYOLS MADE FROM PARTIALLY-EPOXIDIZED, FULLY-HYDROGENATED FATTY ACID ALKYL ESTERS - A method is described for producing polyester polyols by partially-epoxidizing fatty acid alkyl esters having an iodine value from 90 to 190 g I2/100 grams, fully-hydrogenating the partially-epoxidized esters to form hydroxylated fatty acid alkyl esters, and then reacting the hydroxylated fatty acid alkyl esters with a multifunctional ester-reactive initiator compound to form the polyester polyol. | 2012-05-31 |
20120136170 | PROCESS FOR THE MANUFACTURING OF VINYL ACETATE - The present invention relates to a process for the separation of vinyl acetate from a gas mixture formed by the reaction of ethylene with acetic acid and oxygen in the gas phase over catalysts comprising palladium or palladium compounds. | 2012-05-31 |
20120136171 | METHOD FOR THE MANUFACTURE OFAMINO ALKYLENE PHOSPHONIC ACIDS - A method for the manufacture of aminoalkylene phosphonic acids broadly is disclosed. In the essence, an amine corresponding to a specific formula is reacted in aqueous medium with phosphorous acid and formaldehyde to thereby yield a medium insoluble reaction product. The insoluble product formed i.e. the aminoalkylene phosphonic acid can be separated, optionally washed, and recovered. This process yields high purity and selectivity reaction products. The excess phosphonic acid can be recycled into the processing sequence. | 2012-05-31 |
20120136172 | Modularized System and Method for Urea Production Using Stranded Natural Gas - A modular system and method for producing urea from stranded natural gas includes removal of foreign particulate matter to obtain a substantially homogeneous gas. The gas is processed by controlling the quality of the stranded natural gas to maintain a substantially homogenous mixture The resultant gas stream is further cleaned and compressed to a high pressure of about 3,000 psi. The resultant ammonia stream is processed in a bypass recycling loop system at 30% conversion rate at a high pressure of about 6,000 to 7,000 psi. The equipment associated with each of the process steps may be skid mounted for portability and/or contained within the footprint of a standard 48-foot flatbed trailer. | 2012-05-31 |
20120136173 | PROCESS FOR IMPROVING THE CATALYTIC ACTIVITY OF CATALYST SYSTEMS FOR REDUCTIVE AMINATION OF ALIPHATIC CYANOALDEHYDES TO ALIPHATIC DIAMINES - The instant invention provides a process for improving catalytic activity of catalyst systems for reductive amination of aliphatic cyanoaldehydes to aliphatic diamines. The process for improving catalytic activity of catalyst systems for reductive amination of aliphatic cyanoaldehydes to aliphatic diamines comprises the steps of: (1) feeding ammonia, optionally hydrogen, and optionally one or more solvents over one or more heterogeneous metal based catalyst systems having a reduced catalytic activity for a period of greater than 1 hour at a temperature in the range of from 50° C. to 500° C.; wherein said one or more heterogeneous metal based catalyst systems have a yield of less than 90 percent based on the molar conversion of cyanoaldehydes to diamines; and (2) thereby improving the catalytic activity of said one or more heterogeneous metal based catalyst systems. | 2012-05-31 |
20120136174 | Method For Synthesizing Aminoalcohols - The present invention relates to a method for synthesizing amonoalcohols (e.g., aminoalcohols that contain an amine group that is either unsubstituted, mono-substituted, or di-substituted) and to the products formed therefrom. In one embodiment, the present invention relates to a method for synthesizing aminoalcohols from a corresponding aminoaldehyde and to the products formed therefrom. In another embodiment, the present invention relates to a method for synthesizing aminoalcohols from a corresponding aminoaldehyde via a hydrogenation process using a suitable catalyst (e.g., Raney® Nickel) and to the products formed therefrom. In still another embodiment, the present invention relates to aminoalcohols formed via direct hydrogenation from a corresponding aminoaldehyde without the intervening step of converting the aminoaldehyde starting material to a salt. | 2012-05-31 |
20120136175 | PROCESS FOR PREPARATION OF ALKYL SULFONE COMPOUNDS - An object of the present invention is to provide a method for preparation of an alkyl sulfone compound simply and safely with high yield, and an alkyl sulfone compound. | 2012-05-31 |
20120136176 | CATALYST FOR ASYMMETRIC HYDROGENATION AND METHOD FOR MANUFACTURING OPTICALLY ACTIVE CARBONYL COMPOUND USING THE SAME - The present invention provides a catalyst used for manufacturing an optically active carbonyl compound by selective asymmetric hydrogenation of an α,β-unsaturated carbonyl compound, which is insoluble in a reaction mixture, and a method for manufacturing the corresponding optically active carbonyl compound. Particularly, the invention provides a catalyst for obtaining an optically active citronellal useful as a flavor or fragrance, by selective asymmetric hydrogenation of citral, geranial or neral. The invention relates to a catalyst for asymmetric hydrogenation of an α,β-unsaturated carbonyl compound, which comprises: a powder of at least one metal selected from metals belonging to Group 8 to Group 10 of the Periodic Table, or a metal-supported substance in which the at least one metal is supported on a support; an optically active peptide compound; and an acid, and also relates to a method for manufacturing an optically active carbonyl compound using the same. | 2012-05-31 |
20120136177 | Process for Preparation of Hexafluoroacetone Monohydrate - Disclosed is a method for producing hexafluoroacetone monohydrate by (1) allowing, in an organic solvent, hexafluoroacetone to be absorbed into water or a hexafluoroacetone hydrate (water addition method) or by (2) an easy method in which a hexafluoroacetone hydrate is mixed with an organic solvent and then distillation is conducted, thereby removing a mixture of water and the organic solvent as a low-boiling-point composition and obtaining a mixture of hexafluoroacetone monohydrate and the organic solvent as a high-boiling-point composition (dehydration method). | 2012-05-31 |
20120136178 | PROCESS FOR THE PREPARATION OF ETHYLENE GLYCOL - The invention provides a process for the production of ethylene glycol from ethylene. An ethylene glycol stream comprises inorganic chloride contaminants and the process comprises steps of converting the inorganic chloride contaminants to 2-chloroethanol by reaction with ethylene oxide in one or more dehydration columns, and removing 2-chloroethanol in a waste water stream. | 2012-05-31 |
20120136179 | Copper Chromite Hydrogenation Catalysts For Production Of Fatty Alcohols - Provided are hydrogenation catalysts for processing esters into fatty alcohols. More particularly, the catalysts are for vapor-phase hydrogenation of methyl esters to fatty alcohols under fixed-bed conditions, where conditions are typically in a temperature range of 200 to 250° C. and a pressure range of 30 to 50 bar. Methods of making and using the same are also provided. These catalysts comprise a copper chromite, an alkali metal or alkaline earth metal component, and an inorganic matrix component, which are processed together to form the catalyst. The alkali metal component can comprise sodium (Na), potassium (K), rubidium (Rb), caesium (Cs), or combinations thereof. The alkaline earth metal can comprise magnesium (Mg), calcium (Ca), barium (Ba), or combinations thereof. | 2012-05-31 |
20120136180 | Imprinted Biomimetic Catalysts for Cellulose Hydrolysis - The present disclosure describes methods and biomimetic catalysts useful for hydrolyzing glucose polymers, such as cellulose, and oligomers, such as cellobiose, to glucose for the subsequent production of ethanol. | 2012-05-31 |
20120136181 | WASHING SYSTEM FOR NITROAROMATIC COMPOUNDS - A method of removing alkalinity and salt from a nitroaromatic product downstream of water washing to remove mineral acids and alkaline washing to remove salts of organic acids, comprises washing the product stream with an acidic aqueous solution, prior to the step of removing excess organic reactant, by steam stripping or distillation. Acid removed from the stripper or column is recycled back for use in the acidic washing. The acidic washing is done instead of the neutral washing step of the prior art. It removes residual salt and decreases the level of entrained colloidal water in the nitroaromatic product. | 2012-05-31 |
20120136182 | METHOD FOR PRODUCING 2-CHLORO-3,3,3,-TRIFLUOROPROPENE (HCFC-1233xf) - The present invention relates to an improved method for manufacturing 2-chloro-3,3,3,-trifluoropropene (HCFC-1233xf) by reacting 1,1,2,3-tetrachloropropene, 1,1,1,2,3-pentachloropropane, and/or 2,3,3,3-tetrachloropropene with hydrogen fluoride, in a vapor phase reaction vessel in the presence of a vapor phase fluorination catalyst and stabilizer. HCFC-1233xf is an intermediate in the production of 2,3,3,3-tetrafluoropropene (HFO-1234yf) which is a refrigerant with low global warming potential. | 2012-05-31 |
20120136183 | METHOD FOR PREPARING FLUORINE COMPOUNDS - The invention relates to a method for preparing fluoropropenes of formula (I) CF | 2012-05-31 |
20120136184 | NUCLEIC ACID MOLECULE - The invention relates to an isolated nucleic acid molecule encoding a polypeptide capable of producing a triterpenoid hydrocarbon. The invention also relates to the encoded polypeptide, a vector comprising the nucleic acid molecule, a recombinant non-human organism comprising the nucleic acid molecule, and to methods of producing a triterpenoid hydrocarbon or an intermediate of biofuel using the nucleic acid molecule, polypeptide or recombinant organism. | 2012-05-31 |
20120136185 | METHODS FOR PRODUCING FUELS AND SOLVENTS - Described herein are methods for producing fuels and solvents from fatty acid resources. Also disclosed herein are fuels and solvents produced by the methods described herein. | 2012-05-31 |
20120136186 | METHOD FOR PRODUCING LOW-ODOR N-BUTANE - The invention relates to a method for producing low-odor n-butane by catalytic hydrogenation of a feed mixture. The aim of the invention is to provide such a method, wherein the feed material, in addition to n-butane, n-butene and up to 1 mass % formic acid and/or up to 1 mass % pentanals and/or up to 0.5 mass % pentanols, also comprises carbon monoxide. The aim is achieved by treating the feed mixture in the temperature range of 15 to 120° C. with an aqueous solution of an alkali metal or alkaline earth metal hydroxide in the concentration range of 0.5 to 30 mass % and subsequently subjecting the feed mixture to the catalytic hydrogenation. | 2012-05-31 |
20120136187 | UNIT, SYSTEM AND PROCESS FOR CATALYTIC CRACKING - One exemplary embodiment can be a fluid catalytic cracking unit. The fluid catalytic cracking unit can include a first riser, a second riser, and a disengagement zone. The first riser can be adapted to receive a first feed terminating at a first reaction vessel having a first volume. The second riser may be adapted to receive a second feed terminating at a second reaction vessel having a second volume. Generally, the first volume is greater than the second volume. What is more, the disengagement zone can be for receiving a first mixture including at least one catalyst and one or more products from the first reaction vessel, and a second mixture including at least one catalyst and one or more products from the second reaction vessel. Typically, the first mixture is isolated from the second mixture. | 2012-05-31 |
20120136188 | ALKYLATION UNIT AND METHOD OF MODIFYING - One exemplary embodiment can be a method of modifying an alkylation unit to increase capacity. The method may include combining a first alkylation zone with a second alkylation zone. Generally, the first alkylation zone includes a first settler having a height and a width. Typically, the width is greater than the height. In addition, the second alkylation zone may have a second settler having a height and a width. Usually, the height is greater than the width. | 2012-05-31 |
20120136189 | BUFFERED IONIC LIQUIDS FOR OLEFIN DIMERIZATION - The present invention relates generally to buffered ionic liquids that are very useful for dimerization of olefins, such as isopropene, wherein the buffer is a phosphine or a bismuthine or an arsine or an amine. | 2012-05-31 |
20120136190 | PRODUCTION OF 3-METHYLBUT-1-EN BY MEANS OF DEHYDRATION OF 3-METHYLBUTANE-1-OL - The invention relates to a process for preparing 3-methyl-1-butene by dehydration of 3-methyl-1-butanol over an aluminium-containing oxide in the temperature range from 200 to 450° C. in the gas phase or mixed liquid/gas phase, characterized in that an aluminium-containing oxide having a predominantly mesoporous pore structure whose: | 2012-05-31 |
20120136191 | CATALYST AND PROCESS - The invention is a method of dehydrogenating a hydrocarbon, especially an alkane, to form an unsaturated compound, especially an alkene, by contacting the alkane with a catalyst comprising a form of carbon which is catalytically active for the dehydrogenation reaction. The catalyst may be formed by passing a hydrocarbon over a metal compound at a temperature greater than 650° C. | 2012-05-31 |
20120136192 | PROCESS FOR TREATMENT OF ETHYLENE - A process for removing water from an ethylene stream comprising water, said process comprising: introducing an ethylene stream comprising water into, and circulating said ethylene stream through, a separation vessel; introducing a liquid diethyl ether stream into, and circulating said liquid diethyl ether stream through, the separation vessel, so that said liquid diethyl ether stream and said ethylene stream comprising water are brought into contact; recovering an ethylene stream having a reduced water content from the separation vessel; and optionally recovering a liquid diethyl ether stream having an increased water content from the separation vessel. | 2012-05-31 |
20120136193 | APPARATUS AND METHOD FOR HYDROLYZING BIOLOGICAL MATERIAL - Apparatus and method for hydrolyzing biological material for safe disposal thereof without the necessity of incineration or use of disinfectants are described. An alkaline solution having a concentration and an amount effective for hydrolyzing the biological material is brought into contact therewith by means of rotating paddles which both pound the biological material into small pieces and thoroughly mix the alkaline solution with the material under pressure and at elevated temperature. Following the hydrolysis of the biological material, a chosen portion of the water is removed from the alkaline solution and from the liquefied biological material, such that the resulting product solidifies when cooled. The present safe disposal of the biological material does not require incineration thereof, the addition of disinfectants thereto, or the discharge of liquid effluent containing processed biological material into the sewage system. | 2012-05-31 |
20120136194 | AUTOMATED TREATMENT PLANNING FOR RADIATION THERAPY - This patent generally relates to developing treatment plans for use in external beam radiation therapy, and more particularly to a method, a system and a computer readable media that contains programming for the development of external beam radiation therapy treatment plans. Embodiments of the invention include (1) automatically setting beam angles based on a beam angle automation algorithm, (2) judiciously designing planning structures and (3) automatically adjusting the objectives of the objective function based on a parameter automation algorithm. | 2012-05-31 |
20120136195 | DRUG DELIVERY SYSTEM OF TARGET DRUG AND METHOD OF IMPLEMENTING THE SAME - A drug delivery system of a target drug and method of implementing the same. Said drug delivery system of target drug comprising: a plurality of drug-carrying magnetic particles, a magnetic field generation device, and an ultrasound generation device. Said magnetic field generation device generates a magnetic field to guide said magnetic particles to a target activity position; and said ultrasound generation device generates ultrasound to make said magnetic particles into a suspension state, thus increasing reaction area, enhancing local reaction of drug, such that local retention of drug is able to achieve maximum therapeutic effects at reduced drug dosage. | 2012-05-31 |
20120136196 | MOBILE IMAGING UNIT WITH ENVIRONMENTAL CONTAINMENT - A system comprises: an isolation tube ( | 2012-05-31 |
20120136197 | HEARING PROSTHESIS HAVING A FLEXIBLE ELONGATE ENERGY TRANSFER MECHANISM - Aspects of the present invention are generally directed to using a flexible conductor for transmitting energy to a recipient's cochlea. The flexible conductor may be used to transmit mechanical energy, such as sound vibrations, to the cochlea from an actuator implanted, for example, in a recess in the mastoid bone of the recipient. The flexible conductor may be coupled at its distal end to a component of the recipient's middle or inner ear. In operation, mechanical movement (e.g., vibrations) may be transferred from the actuator to the middle or inner ear of the recipient by the flexible conductor. These vibrations then induce movement of perliymph in the recipient's cochlea to cause, for example, perception of the sound by the recipient. | 2012-05-31 |
20120136198 | LIGHT TREATMENT APPARATUS - A light treatment apparatus for simulating a psychophysical borderline experience comprises a light emitting apparatus for emitting light perceivable by the human eye as well as a control apparatus for controlling the light emission apparatus. Said light emission apparatus has at least one permanent light source as well as at least one flickering light source whose flickering light can be superimposed on the permanent light of the permanent light source in the region of a treatment area, with the control apparatus having a frequency control module which increases or reduces the frequency of the flickering light source from a starting frequency to a target frequency in at least one acceleration passage. | 2012-05-31 |
20120136200 | SURGICAL STABILIZER AND CLOSURE SYSTEM - A system for stabilizing the heart via a helical needle, providing access to the interior of the heart via an introducer sheath, and forming a purse string suture using suture delivered by the helical needle. A helical needle projects distally from the device and terminates in a sharp distal tip. The helical needle is advanced into the heart wall, and is used to stabilize the heart and to pass a purse string suture through the heart tissue. An access port provides access to the interior of the heart via an opening passing through the heart wall in an area circumscribed by the helical needle. The helical needle may have a deflection segment adjacent the distal tip that is more flexible than the rest of the helical distal portion of the helical needle. | 2012-05-31 |
20120136201 | CARDIAC SUPPORT DEVICE - A highly compliant and elastic cardiac support device is provided. The device is constructed from a biocompatible material is applied to an external surface of a heart. The device can be used to resist dilatation of the heart, to provide acute wall support, or to enhance reduction in the size of the heart using stored potential energy, without interfering with systolic contraction. | 2012-05-31 |
20120136202 | METHOD AND APPARATUS FOR EXTERNAL STABILIZATION OF THE HEART - The present disclosure is directed to an external cardiac basal annuloplasty system (ECBAS or BACE-System: basal annuloplasty of the cardia externally) and methods for treatment of regurgitation of mitral and tricuspid valves. The BACE-System provides the ability to correct leakage of regurgitation of the valves with or without the use of cardiopulmonary bypass, particularly when the condition is related to dilation of the base of the heart. This ECBAS invention can be applied to the base of the heart epicardially, either to prevent further dilation or to actively reduce the size of the base of the heart. | 2012-05-31 |
20120136207 | Endoscopic Methods and Devices for Transnasal Procedures - Medical devices, systems and methods that are useable to facilitate transnasal insertion and positioning of guidewires and various other devices and instruments at desired locations within the ear, nose, throat, paranasal sinuses or cranium. | 2012-05-31 |
20120136208 | MEDICAL IMAGE PROCESSING APPARATUS METHOD AND PROGRAM - An observation path setting unit sets an observation path. A viewpoint setting and changing unit sets a viewpoint on the observation path. When a virtual endoscopic image viewed from the viewpoint is generated, a visual range determination unit identifies, based on a three-dimensional medical image, the position of a wall region of the tubular structure in a local observation direction at the viewpoint that has been set by the viewpoint setting and changing unit and in the vicinity of the local observation direction. The visual range determination unit estimates, based on a positional relationship between the viewpoint and the wall region, a global observation direction at the viewpoint, and determines a visual range of the virtual endoscopic image in such a manner that image information about a region located in the global observation direction with respect to the viewpoint is represented at a central part of the virtual endoscopic image. | 2012-05-31 |
20120136209 | METHODS AND DEVICES FOR PROVIDING INFORMATION USEFUL IN THE DIAGNOSIS OF ABNORMALITIES OF THE GASTROINTESTINAL TRACT - Disclosed are methods useful for providing information useful in the diagnosis of gastrointestinal abnormalities as well as ingestible devices useful for providing information useful in the diagnosis of gastrointestinal abnormalities. | 2012-05-31 |
20120136210 | ASSEMBLY FOR ENDOSCOPE - An assembly for the endoscope is composed of a tubular member, a positioning ring, and a sleeve. The tubular member on its external wall includes a first threaded portion and a second threaded portion spaced from the first threaded portion. The positioning ring includes a threaded part formed on an internal wall thereof for axial movement along the tubular member. The sleeve includes a threaded section formed on an internal wall thereof. When the sleeve is sleeved onto the tubular member, the threaded section is located between the first and second threaded portions and stopped against the first threaded portion; meanwhile, the positioning ring can be pushed against the sleeve to fasten the sleeve onto the tubular member. Accordingly, the sleeve can be accurately, rapidly, and conveniently positioned onto the tubular member. | 2012-05-31 |
20120136211 | ILLUMINATION OPTICAL UNIT FOR ENDOSCOPE, METHOD OF MANUFACTURING THE SAME, AND ADHESIVE FOR ENDOSCOPE OPTICAL MEMBER - An adhesive disposed between a protective cover and a sleeve member is prevented from flowing in to a position where a fluorescent body should be originally arranged. An illumination optical unit includes an optical fiber, a fluorescent body, a ferrule as a holding member holding the fluorescent body and the optical fiber, a tubular sleeve member that covers the outer periphery of the fluorescent body, and a protective cover that seals the distal end of the sleeve member. The ferrule holds the fluorescent body and is fitted into a fitting hole of the sleeve member. Since glass beads are mixed into an adhesive that bonds the protective cover to a receiving portion of the sleeve member, excessive flow of the adhesive can be suppressed. | 2012-05-31 |
20120136212 | ILLUMINATION OPTICAL UNIT FOR ENDOSCOPE AND METHOD OF MANUFACTURING THE SAME - The periphery of a fluorescent body is reliably sealed, and entry of moisture or volatilized gas is prevented. An illumination optical unit includes an optical fiber, a fluorescent body, a ferrule as a holding member holding the fluorescent body and the optical fiber, a tubular sleeve member that covers the outer periphery of the fluorescent body, and a protective cover. The ferrule holds the fluorescent body and is fitted into a fitting hole of the sleeve member. An inner peripheral face of the sleeve member and an outer peripheral face of the protective cover are bonded together to seal the distal end side of the fluorescent body, and the fitting hole of the sleeve member and an outer peripheral face of the ferrule are bonded together to bond the proximal end side of the fluorescent body. | 2012-05-31 |
20120136213 | ENDOSCOPE - A rigid, rod-shaped endoscope for medical applications includes a distal end having a light-permeable distal window and a light outlet disposed adjacent to the distal window, which includes a device configured to prevent the incidence of stray light onto sides of the deflection prism facing the distal window. An endoscope shank includes a plurality of telescoping hollow tubes. An inner fixed optical tube includes a moveable optical deflection prism and an optical system configured to transmit light beams. The optical deflection prism is mounted rotatably on a shaft that is disposed at a right angle to a longitudinal axis of the endoscope. At least one moveable sliding tube is configured to move relative to the inner fixed optical tube in the direction of the longitudinal axis of the endoscope using magnetic forces generated by a plurality of moveable permanent magnets. | 2012-05-31 |
20120136214 | SURGICAL HAND ACCESS APPARATUS - A surgical access apparatus includes a liner base and an access housing for positioning outside the body. The liner base includes an inner member adapted for insertion through an opening within body tissue for positioning within the body; a sleeve member connected to the inner member and dimensioned to extend from the inner member through the opening within the body tissue, and a plurality of tensioning elements connected to the inner member and associated with the sleeve member to impart a tensioning effect on the sleeve member. The access housing includes a first element and a second element. The second element is operatively connected to the tensioning elements and adapted for rotational movement relative to the first member to cause the tensioning elements to displace the inner member toward the access housing and to cause the sleeve member to engage and retract tissue defining the opening within the body. | 2012-05-31 |
20120136215 | Adjustable Rail Clamp with Clamp Locking Device - An adjustable surgical retractor clamping mechanism for attaching mechanism to an operating table. The mechanism includes an upper jaw, lower jaw, a drive member, an adjustable frame support post and a releasable clamp for adjusting the height of the surgical retracting frame. The upper portion of the lower jaw has a plurality of slots cut into the sidewalls of upper jaw to form at least one flexible finger. The clamp is in close sliding relationship to the upper portion of lower jaw member. The clamp includes a cam lever. Movement of the cam lever to its closed position compresses the clamp causing the flexible fingers to grip the adjustable post locking its longitudinal movement. Rotation of the cam lever to the open position releases the compressive force on the clamp, unlocking the adjustable post allowing the post to be longitudinally adjusted relative to the clamping mechanism. | 2012-05-31 |
20120136216 | FILM ILLUMINATION SYSTEM - An illuminator film system may include one or more pre-cut sections of optical film applied to a waveguide to allow light to exit the waveguide through the film in a predetermined manner. The one or more pre-cut sections may be removed and reapplied during a procedure to redirect the light. A laminated illuminator film may be provided that uses a laminated optical film structure to direct light from a fiber optic input. Such a laminated illuminator film may be very low profile, low cost and easy to apply to a retractor for providing illumination during a surgical procedure. | 2012-05-31 |
20120136217 | SYSTEM AND METHOD FOR NON-INTRUSIVE HEALTH MONITORING IN THE HOME - A hand-held device, such as a remote control, is provided for operation of a consumer appliance and is equipped with one or more biometric sensors to capture and report on the health condition of a user of the hand-held device. The data captured by such a hand-held device may be evaluated locally in the hand-held device itself or may be conveyed to a target consumer appliance either for local evaluation by that consumer appliance or for onward transmission to a central off-site monitoring service. | 2012-05-31 |
20120136218 | REMOTE HEALTHCARE SYSTEM AND HEALTHCARE METHOD USING THE SAME - A remote healthcare system and healthcare method using the same are provided. A healthcare method includes accessing a healthcare system, acquiring vital information of a user who accesses the healthcare system, and displaying a progress state of a healthcare service and a health of the user as an image based on the vital information. | 2012-05-31 |
20120136219 | EMOTION SCRIPT GENERATING, EXPERIENCING, AND EMOTION INTERACTION - An emotion script generating apparatus, comprising means to receive emotion data, in which the emotion data is obtained according to measurable physiological parameters reflective of a user's emotions; and means to generate emotion script using the emotion data based on a predefined template. An emotion script experiencing apparatus, comprising means to receive emotion script, wherein the emotion script is generated using emotion data and is based on a predefined template, the emotion data capable of being obtained according to measurable physiological parameters reflective of a user's emotions; and means to affect a user by using emotion data extracted from the emotion script, so as to cause the user to experience the emotion script. | 2012-05-31 |
20120136220 | COMPOSITIONS AND METHODS FOR ENHANCING BRAIN FUNCTION - Compositions and methods are provided that enhance cognition in a human to which the composition is orally administered. Remarkably, clinical studies have proven that contemplated compositions achieve the desired effects using a minimal number of active ingredients at or near threshold active dosages, wherein such compositions almost exclusively comprise huperzine A, vinpocetine or rhodiola, and acetyl-L-carnitine, and optionally further include alpha lipoic acid, rhodiola, and biotin. | 2012-05-31 |
20120136221 | System and method for monitoring the health of a hospital patient - A system for monitoring the health of a hospital patient. The system includes a score engine configured to identify the status of a patient's health using one or more measurements relating to the patient, and a list manager configured to identify a medical practitioner associated with the patient. The system is configured to send a message to the medical practitioner in dependence on the identified status of the patient's health. A corresponding method is also provided. | 2012-05-31 |
20120136222 | Methods And Systems For Monitoring A Ventilator Patient With A Capnograph - This disclosure describes systems and methods for monitoring the ventilation of a patient being ventilated by a medical ventilator. The disclosure describes a novel approach of displaying integrated ventilator information with capnography data. The disclosure further describes a novel approach for removing cardiogenic artifacts. | 2012-05-31 |
20120136223 | MULTIPLE SENSOR ASSEMBLIES AND CABLES IN A SINGLE SENSOR BODY - A multisystem sensor is disclosed that includes a first sensor subsystem and a second sensor subsystem. The multisystem sensor includes a sensor body having both sensor subsystems. The first sensor subsystem may monitor a first physiological characteristic and the second sensor subsystem may monitor a second physiological characteristic. The sensor body may include an isolating portion configured to isolate the first sensor subsystem and the second sensor subsystem. The sensor body and/or isolating portion may include refractive components and/or filters to prevent interference between sensor subsystems. | 2012-05-31 |
20120136224 | Combining Predictive Capabilities of Transcranial Doppler (TCD) with Electrocardiogram (ECG) to Predict Hemorrhagic Shock - A real-time decision-support system predicts hemorrhagic shock of a patient by analysis of electrocardiogram (ECG) signals and transcranial Doppler (TCD) signals from the patient. These signals are subject to signal decomposition using Discrete Wavelet Transform (DWT) to sets of wavelet coefficients and selecting significant signal features. Machine learning is applied to the significant features to evaluate and classify hypovolemia severity based on the input ECG and TCD signals from the patient. The classification of blood loss severity is displayed in real-time. An extension of the decision-support system integrates Arterial Blood Pressure (ABP) signals and thoracic electrical bio-impedance (DZT) signals with the ECG and TCD signals from the patient to evaluate severity of hypovolemia. | 2012-05-31 |
20120136225 | METHOD FOR SPECTROPHOTOMETRIC BLOOD OXYGENATION MONITORING OF THE LOWER GASTROINTESTINAL TRACT - A method and apparatus for non-invasively determining a blood oxygen saturation level and/or the presence of fecal matter within a subject's lower GI tissue is provided. The method includes the steps of: a) providing a spectrophotometric sensor operable to transmit light into the subject's tissue, and to sense the light; b) sensing the subject's lower GI Tissue Using the Sensor, and Producing signal data from sensing the subject's tissue; c) processing the signal data, including determining the presence of one or more wavelength dependent light absorbing materials not present within blood within the subject's lower GI tract from the signal data; and d) determining the blood oxygen saturation level and/or presence of fecal matter within the subject's lower GI tissue, including accounting for the presence of the wavelength dependent light absorbing material not present within blood within the subject's lower GI tract determined using the signal data. | 2012-05-31 |
20120136226 | Pulse Oximetry For Determining Heart Rate Variability As A Measure Of Susceptibility To Stress - Embodiments of the present disclosure relate to systems and methods for determining a physiologic parameter of a patient. Specifically, embodiments provided herein include methods and systems for determining or predicting the presence and/or severity of stress in a patient based on heart rate variability. The information relating to stress may be used as part of a broader physiological assessment. | 2012-05-31 |